For the first time in decades, the Food and Drug Administration has approved a new type of drug for schizophrenia. The ...
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.
People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...
"The market at this point..(is) pretty much pricing in a soft landing, and pricing in that we have defeated inflation, and ...